Concepedia

Andrew Do

AD

15

Publications

761

Citations

13

H-Index

2013

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Greater Poland Cancer Center

University of Central Florida

Medical University of Lodz

Andrew Do is an author at Massachusetts General Hospital specializing in medicine, physiology, and radiation oncology.

ORCID

Top concepts

Publications per year

2013–2023

15

Publications

15

MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

Ibiayi Dagogo‐Jack, Satoshi Yoda, Jochen K. Lennerz et al. · Clinical Cancer Research · 2020 · 188 citations · Full text

Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung Cancer

Noura J. Choudhury, Satoshi Yoda, Viola W. Zhu et al. · Clinical Cancer Research · 2021 · 132 citations · Full text

Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition

Adam Langenbucher, Pranav Gupta, Satoshi Yoda et al. · npj Precision Oncology · 2020 · 65 citations · Full text

Analysis of lorlatinib analogs reveals a roadmap for targeting diverse compound resistance mutations in ALK-positive lung cancer

Aya Shiba‐Ishii, Ted W. Johnson, Ibiayi Dagogo‐Jack et al. · Nature Cancer · 2022 · 63 citations · Full text

, , +9

A Phase 2 Study of Capmatinib in Patients With MET-Altered Lung Cancer Previously Treated With a MET Inhibitor

Ibiayi Dagogo‐Jack, Philicia Moonsamy, Justin F. Gainor et al. · Journal of Thoracic Oncology · 2021 · 62 citations · Full text

, , +9

Rows per page

1–5 of 15